These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 15800824

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA, Carey D, Hills AP, Hooper M, Marks S, Proietto J, Strauss BJ, Sullivan D, Welborn TA, Caterson ID.
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [Abstract] [Full Text] [Related]

  • 3. Blood lipids profile in obese or overweight patients.
    Szczygielska A, Widomska S, Jaraszkiewicz M, Knera P, Muc K.
    Ann Univ Mariae Curie Sklodowska Med; 2003 May; 58(2):343-9. PubMed ID: 15323217
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Associated atherothrombotic disease risk factors in diabetes and prediabetes.
    Feeman WE.
    Am J Med; 2006 May; 119(5):e19. PubMed ID: 16651039
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical advances in diabetes].
    Martin S, Scherbaum WA.
    Dtsch Med Wochenschr; 2006 Jun 23; 131(25-26):1461-2. PubMed ID: 16794976
    [No Abstract] [Full Text] [Related]

  • 11. Abdominal obesity is associated with ineffective control of cardiovascular risk factors in primary care in France.
    Dallongeville J, Bringer J, Bruckert E, Charbonnel B, Dievart F, Komajda M, Pouchain D, Amouyel P.
    Diabetes Metab; 2008 Dec 23; 34(6 Pt 1):606-11. PubMed ID: 19019717
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Unmet needs in controlling metabolic disease.
    Haffner SM.
    Rev Cardiovasc Med; 2007 Dec 23; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Obesity and cardiovascular risk: the new public health problem of worldwide proportions.
    Scaglione R, Argano C, Di Chiara T, Licata G.
    Expert Rev Cardiovasc Ther; 2004 Mar 23; 2(2):203-12. PubMed ID: 15151469
    [Abstract] [Full Text] [Related]

  • 18. New drugs and clinical trials in diabetes and hypertension.
    Nilsson P.
    Exp Clin Endocrinol Diabetes; 1997 Mar 23; 105 Suppl 2():64-9. PubMed ID: 9288549
    [Abstract] [Full Text] [Related]

  • 19. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
    Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ.
    Menopause; 2007 Mar 23; 14(4):624-9. PubMed ID: 17290158
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.